BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14586630)

  • 21. The impact of a ten-week physical exercise program on health-related quality of life in patients with inflammatory bowel disease: a prospective randomized controlled trial.
    Klare P; Nigg J; Nold J; Haller B; Krug AB; Mair S; Thoeringer CK; Christle JW; Schmid RM; Halle M; Huber W
    Digestion; 2015; 91(3):239-47. PubMed ID: 25823689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing patient satisfaction in inflammatory bowel disease using the QUOTE-IBD survey: a small step for clinicians, a potentially large step for improving quality of care.
    Vasudevan A; Arachchi A; van Langenberg DR
    J Crohns Colitis; 2013 Oct; 7(9):e367-74. PubMed ID: 23528836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The IMPACT-III (HR) questionnaire: a valid measure of health-related quality of life in Croatian children with inflammatory bowel disease.
    Abdovic S; Mocic Pavic A; Milosevic M; Persic M; Senecic-Cala I; Kolacek S
    J Crohns Colitis; 2013 Dec; 7(11):908-15. PubMed ID: 23333037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Internet-orientated Assessment of QOL and Actual Treatment Status in Japanese Patients with Inflammatory Bowel Disease: The 3I survey.
    Matsumoto T; Yanai S; Toya Y; Ueno M; Nakamura S
    J Crohns Colitis; 2015 Jun; 9(6):477-82. PubMed ID: 25814388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Back/joint pain, illness perceptions and coping are important predictors of quality of life and work productivity in patients with inflammatory bowel disease: a 12-month longitudinal study.
    van der Have M; Brakenhoff LK; van Erp SJ; Kaptein AA; Leenders M; Scharloo M; Veenendaal RA; van der Heijde DM; van der Meulen-de Jong AE; Hommes DW; Fidder HH
    J Crohns Colitis; 2015 Mar; 9(3):276-83. PubMed ID: 25547976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: a cross-sectional, observational study.
    Gibson PR; Vaizey C; Black CM; Nicholls R; Weston AR; Bampton P; Sparrow M; Lawrance IC; Selby WS; Andrews JM; Walsh AJ; Hetzel DJ; Macrae FA; Moore GT; Weltman MD; Leong RW; Fan T
    J Crohns Colitis; 2014 Jul; 8(7):598-606. PubMed ID: 24345767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Quality of life assessment in Inflammatory Bowel Disease (IBD): German version of the Inflammatory Bowel Disease Questionnaire (IBDQ-D; disease-specific instrument for quality of life assessment) -- first application and comparison with international investigations].
    Janke KH; Steder-Neukamm U; Bauer M; Raible A; Meisner C; Hoffmann JC; Gregor M; Klump B; Häuser W
    Gesundheitswesen; 2005; 67(8-9):656-64. PubMed ID: 16217720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coping is excellent in Swiss Children with inflammatory bowel disease: results from the Swiss IBD cohort study.
    Rogler D; Fournier N; Pittet V; Bühr P; Heyland K; Friedt M; Koller R; Rueger V; Herzog D; Nydegger A; Schäppi M; Schibli S; Spalinger J; Rogler G; Braegger CP;
    J Crohns Colitis; 2014 May; 8(5):409-20. PubMed ID: 24230970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Validation of the German version of the Inflammatory Bowel Disease Questionnaire (Competence Network IBD, IBDQ-D)].
    Janke KH; Klump B; Steder-Neukamm U; Hoffmann J; Häuser W
    Psychother Psychosom Med Psychol; 2006 Jul; 56(7):291-8. PubMed ID: 16715461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistent or Recurrent Anemia Is Associated With Severe and Disabling Inflammatory Bowel Disease.
    Koutroubakis IE; Ramos-Rivers C; Regueiro M; Koutroumpakis E; Click B; Schoen RE; Hashash JG; Schwartz M; Swoger J; Baidoo L; Barrie A; Dunn MA; Binion DG
    Clin Gastroenterol Hepatol; 2015 Oct; 13(10):1760-6. PubMed ID: 25862987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fatigue in a population-based cohort of patients with inflammatory bowel disease 20 years after diagnosis: The IBSEN study.
    Huppertz-Hauss G; Høivik ML; Jelsness-Jørgensen LP; Opheim R; Henriksen M; Høie O; Hovde Ø; Kempski-Monstad I; Solberg IC; Jahnsen J; Hoff G; Moum B; Bernklev T
    Scand J Gastroenterol; 2017 Mar; 52(3):351-358. PubMed ID: 27852169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease (IBD) in Germany: an online IBD registry.
    Bokemeyer B; Hardt J; Hüppe D; Prenzler A; Conrad S; Düffelmeyer M; Hartmann P; Hoffstadt M; Klugmann T; Schmidt C; Weismüller J; Mittendorf T; Raspe H
    J Crohns Colitis; 2013 Jun; 7(5):355-68. PubMed ID: 22503168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The contribution of clinical and psychosocial factors to fatigue in 182 patients with inflammatory bowel disease: a cross-sectional study.
    Artom M; Czuber-Dochan W; Sturt J; Murrells T; Norton C
    Aliment Pharmacol Ther; 2017 Feb; 45(3):403-416. PubMed ID: 27868215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses-Part I.
    Knowles SR; Graff LA; Wilding H; Hewitt C; Keefer L; Mikocka-Walus A
    Inflamm Bowel Dis; 2018 Mar; 24(4):742-751. PubMed ID: 29562277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial.
    Irvine EJ; Zhou Q; Thompson AK
    Am J Gastroenterol; 1996 Aug; 91(8):1571-8. PubMed ID: 8759664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disability in Restorative Proctocolectomy Recipients Measured using the Inflammatory Bowel Disease Disability Index.
    Lee Y; McCombie A; Gearry R; Frizelle FA; Vanamala R; Leong RW; Eglinton T
    J Crohns Colitis; 2016 Dec; 10(12):1378-1384. PubMed ID: 27282401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of Quality of Life and Social Support in Inflammatory Bowel Disease.
    Katz L; Tripp DA; Ropeleski M; Depew W; Curtis Nickel J; Vanner S; Beyak MJ
    J Clin Psychol Med Settings; 2016 Mar; 23(1):88-98. PubMed ID: 26280991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health-related quality of life in inflammatory bowel disease patients: the role of psychopathology and personality.
    Vidal A; Gómez-Gil E; Sans M; Portella MJ; Salamero M; Piqué JM; Panés J
    Inflamm Bowel Dis; 2008 Jul; 14(7):977-83. PubMed ID: 18275078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A national survey on the patterns of treatment of inflammatory bowel disease in Canada.
    Hilsden RJ; Verhoef MJ; Best A; Pocobelli G
    BMC Gastroenterol; 2003 Jun; 3():10. PubMed ID: 12791168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient subjective assessment of drug side effects in inflammatory bowel disease.
    Cross RK; Lapshin O; Finkelstein J
    J Clin Gastroenterol; 2008 Mar; 42(3):244-51. PubMed ID: 18223502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.